Spine Top Stories Spine BioPharma, Inc. Announces Completion of Enrollment for Phase 3 Clinical Trial of SB-01 to Address Chronic Low Back Pain byJosh SandbergSeptember 24, 2024
Regulatory Spine DiscGenics Announces US FDA Approval to Proceed with Phase III Clinical Evaluation of Allogeneic, Injectable Disc Progenitor Cell Therapy for Symptomatic Lumbar Degenerative Disc Disease byTim AllenJuly 16, 2024
Recon Pacira BioSciences Announces Positive Topline Data from Phase 3 Study of EXPAREL as a Single-dose Femoral Nerve Block in the Adductor Canal for Total Knee Arthroplasty byJosh SandbergSeptember 7, 2022
Biologics Spine Top Stories Spine BioPharma Announces First Patient Treated in U.S. Phase 3 Clinical Study byChris StewartSeptember 7, 2022
Hospitals Histogenics Corporation Announces Amendment to NeoCart® Phase 3 Clinical Trial Enrollment Criteria byJosh SandbergDecember 22, 2015
